Longitudinal circulating tumor DNA (ctDNA) analysis during treatment (Tx) of locally advanced resectable (LAR) gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ADENOCA): The PLAGAST prospective biomarker study.
Aziz Zaanan(Hôpital Européen Georges-Pompidou), Pierre Laurent‐Puig(Inserm), Audrey Didelot(Inserm), Minetta C. Liu(Mayo Clinic), Punashi Dutta(Natera (United States)), Meenakshi Malhotra(Natera (United States)), George Laliotis(The Ohio State University), Widad Lahlou(Université Paris Cité), Francesco Giulio Sullo(Université Paris Cité), Antoine Mariani(Université Paris Cité), Aurélien Saltel(Université Paris Cité), Chloé Broudin(Assistance Publique – Hôpitaux de Paris), Shruti Sharma(Natera (United States)), Adham Jurdi(University of the Incarnate Word)
Cited by 5
Related Papers
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k